Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

NCT01142414 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: cisplatin
DRUG: fluorouracil
OTHER: laboratory biomarker analysis
PROCEDURE: adjuvant therapy
PROCEDURE: quality-of-life assessment
RADIATION: 3-dimensional conformal radiation therapy
RADIATION: intensity-modulated radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC